KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Acquisitions (2016 - 2025)

Merck (MRK) has disclosed Acquisitions for 14 consecutive years, with $10.0 billion as the latest value for Q4 2025.

  • Quarterly Acquisitions rose 847.17% to $10.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.0 billion through Dec 2025, changed N/A year-over-year, with the annual reading at $10.0 billion for FY2025, N/A changed from the prior year.
  • Acquisitions for Q4 2025 was $10.0 billion at Merck, up from -$1.3 billion in the prior quarter.
  • The five-year high for Acquisitions was $10.0 billion in Q4 2025, with the low at -$1.3 billion in Q4 2024.
  • Average Acquisitions over 4 years is $1.0 billion, with a median of $83.0 million recorded in 2021.
  • Peak annual rise in Acquisitions hit 12200.0% in 2022, while the deepest fall reached 234.44% in 2022.
  • Over 4 years, Acquisitions stood at $90.0 million in 2021, then plummeted by 234.44% to -$121.0 million in 2022, then crashed by 1010.74% to -$1.3 billion in 2024, then surged by 847.17% to $10.0 billion in 2025.
  • According to Business Quant data, Acquisitions over the past three periods came in at $10.0 billion, -$1.3 billion, and $598.0 million for Q4 2025, Q4 2024, and Q3 2024 respectively.